Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 9Gastrointestinal 5Genitourinary 3Thoracic 2Other neoplasm 2Other hematologic neoplasm 2Head & Neck 2CNS 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1

Interventions

Rituximab 29Surveys and Questionnaires 25Blood Specimen Collection 17Gene Expression Profiling 15Flow Cytometry 14Polymerase Chain Reaction 13Amplified Fragment Length Polymorphism Analysis 13Microarray Analysis 11Observation 10Interviews as Topic 10Psychiatric Rehabilitation 9Lenalidomide 9Immunohistochemistry 9Cytogenetic Analysis 9obinutuzumab 8Watchful Waiting 8Therapeutics 8ibrutinib 7Drug Therapy 7Cyclophosphamide 7Bendamustine Hydrochloride 7Vincristine 6Prednisone 6Magnetic Resonance Spectroscopy 6fludarabine 5In Situ Hybridization, Fluorescence 5Immunologic Techniques 5Data Collection 5Biopsy 5zanubrutinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Mass Spectrometry × Lymphoid × Clear all
NCT01366170 2016-05-19

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

Children's Oncology Group

Completed
7 enrolled
Lymphoid

Lymphoma, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡